In this video, hear how key recommendations from the 2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease may affect TAVI practices and adoption, including continued endorsement of the practice of the Heart Team, new international randomised controlled trials demonstrating the effectiveness of TAVI in intermediate-risk patients, and long-term follow-up of these patients to be shared by all members of the Heart Team.
